X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22136) 22136
Book Review (3688) 3688
Publication (1911) 1911
Newsletter (240) 240
Conference Proceeding (47) 47
Book Chapter (37) 37
Dissertation (19) 19
Newspaper Article (17) 17
Magazine Article (8) 8
Book / eBook (1) 1
Data Set (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19793) 19793
humans (18029) 18029
male (9845) 9845
female (9712) 9712
middle aged (7863) 7863
adult (7461) 7461
interferon-alpha - therapeutic use (7234) 7234
interferon-alpha (6995) 6995
interferon (4947) 4947
antiviral agents - therapeutic use (4653) 4653
treatment outcome (4562) 4562
aged (4451) 4451
recombinant proteins (4103) 4103
hepatitis c, chronic - drug therapy (3814) 3814
gastroenterology & hepatology (3759) 3759
animals (3711) 3711
oncology (3710) 3710
biological response modifiers (3078) 3078
hepatitis c (3066) 3066
interferon-alpha - administration & dosage (2998) 2998
immunology (2980) 2980
drug therapy, combination (2967) 2967
therapy (2874) 2874
ribavirin - therapeutic use (2870) 2870
hepacivirus - genetics (2523) 2523
interferon alpha (2403) 2403
hepatitis c virus (2399) 2399
health aspects (2385) 2385
care and treatment (2371) 2371
ribavirin (2311) 2311
polyethylene glycols - therapeutic use (2241) 2241
genotype (2183) 2183
analysis (2180) 2180
cancer (2155) 2155
mice (2127) 2127
interferon-alpha - pharmacology (2121) 2121
virology (2019) 2019
infection (1993) 1993
abridged index medicus (1951) 1951
interferon-alpha - adverse effects (1884) 1884
research (1761) 1761
virus-infection (1752) 1752
expression (1623) 1623
antiviral agents - administration & dosage (1592) 1592
antineoplastic agents - therapeutic use (1570) 1570
adolescent (1556) 1556
hepatitis (1549) 1549
infectious diseases (1518) 1518
hematology (1498) 1498
prognosis (1497) 1497
retrospective studies (1493) 1493
pharmacology & pharmacy (1470) 1470
hepatitis c, chronic - virology (1460) 1460
recombinant proteins - therapeutic use (1436) 1436
time factors (1416) 1416
drug therapy (1400) 1400
hepatitis c - drug therapy (1360) 1360
viral load (1320) 1320
biochemistry & molecular biology (1248) 1248
ribavirin - administration & dosage (1243) 1243
cytokines (1242) 1242
antiviral agents - adverse effects (1219) 1219
risk factors (1219) 1219
hepacivirus - drug effects (1215) 1215
plus ribavirin (1190) 1190
cell biology (1170) 1170
follow-up studies (1167) 1167
genetic aspects (1158) 1158
survival (1146) 1146
young adult (1126) 1126
carcinoma, renal cell - drug therapy (1108) 1108
medicine & public health (1099) 1099
kidney neoplasms - drug therapy (1083) 1083
prospective studies (1078) 1078
virus diseases (1072) 1072
dendritic cells (1055) 1055
article (1053) 1053
immunotherapy (1042) 1042
rna, viral - blood (1041) 1041
survival analysis (1038) 1038
aged, 80 and over (1033) 1033
cells, cultured (1021) 1021
interferon alpha-2 (1001) 1001
gene expression (984) 984
rna (975) 975
infections (965) 965
antineoplastic combined chemotherapy protocols - therapeutic use (961) 961
interferon-alpha - metabolism (959) 959
polyethylene glycols - administration & dosage (958) 958
cell line (953) 953
liver (949) 949
cells (939) 939
activation (926) 926
viruses (906) 906
kidney neoplasms - pathology (898) 898
proteins (898) 898
dose-response relationship, drug (895) 895
antiviral agents - pharmacology (870) 870
chronic hepatitis-c (855) 855
medicine, research & experimental (848) 848
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21706) 21706
Chinese (138) 138
Russian (112) 112
French (111) 111
Japanese (101) 101
German (91) 91
Spanish (60) 60
Korean (26) 26
Polish (25) 25
Italian (12) 12
Portuguese (9) 9
Serbian (9) 9
Czech (7) 7
Hungarian (7) 7
Turkish (6) 6
Dutch (4) 4
Danish (3) 3
Ukrainian (3) 3
Croatian (2) 2
Slovak (2) 2
Swedish (2) 2
Finnish (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 2012, Volume 156, Issue 4, pp. 279 - 290
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2011, Volume 6, Issue 2, pp. e17232 - e17232
textabstractBackground: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome following interferon/ribavirin therapy... 
GENETIC-VARIATION | IL28B | CLEARANCE | PLUS RIBAVIRIN | VIRUS-INFECTION | THERAPY | PEGINTERFERON ALPHA-2A | PROTEIN-10 | BIOLOGY | VIRAL RESPONSE | ASSOCIATION | Prognosis | Humans | Middle Aged | Polymorphism, Single Nucleotide - physiology | Male | Recombinant Proteins | Interleukins - analysis | Interleukins - metabolism | Interleukins - genetics | Chemokine CXCL10 - analysis | RNA, Viral - genetics | Adult | Female | Biomarkers, Pharmacological - analysis | Pharmacogenetics | Drug Administration Schedule | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Interferon-alpha - administration & dosage | Chemokine CXCL10 - genetics | Interferon alpha-2 | Hepatitis C, Chronic - genetics | Biomarkers, Pharmacological - metabolism | Chemokine CXCL10 - metabolism | Medical research | Care and treatment | RNA | Infection | Analysis | Medicine, Experimental | Genetic aspects | Interferon | Single nucleotide polymorphisms | Hepatitis C virus | Hepatitis C | Chromosomes | Health aspects | Therapy | Liver | Infections | Genomes | Single-nucleotide polymorphism | Ribonucleic acid--RNA | Patients | Ribavirin | Virology | Carriers | Hepatitis | Ethics | Infectious diseases | Hospitals | Correlation analysis | Gastroenterology | Predictions | IP-10 protein | Pretreatment | Genotypes | Index Medicus | Pharmacological | Viral | Mikrobiologi inom det medicinska området | Single Nucleotide | genetics | administration & dosage | Interleukins | drug therapy | Interferon-alpha | physiology | diagnosis | Antiviral Agents | analysis | Chemokine CXCL10 | Chronic | Microbiology in the medical area | Biomarkers | metabolism | therapeutic use | Polymorphism | Ribonucleic acid
Journal Article
Journal Article
Journal Article
Statistics in Medicine, ISSN 0277-6715, 02/2012, Volume 31, Issue 4, pp. 328 - 340
Many clinical trials restrict randomisation using stratified blocks or minimisation to balance prognostic factors across treatment groups. It is widely... 
covariates | clinical trials | adjustment | minimisation | stratification | unadjusted analysis | Minimisation | Clinical trials | Unadjusted analysis | Adjustment | Stratification | Covariates | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICAL INFORMATICS | STATISTICS & PROBABILITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | TREATMENT ALLOCATION | CLINICAL-TRIALS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Back Injuries - rehabilitation | Bias | Humans | Carcinoma - mortality | Male | Antineoplastic Agents - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Deoxyribonucleases - therapeutic use | Fibrinolytic Agents - therapeutic use | Female | Back Injuries - surgery | Pleural Effusion - mortality | Carcinoma - drug therapy | Data Interpretation, Statistical | Randomized Controlled Trials as Topic - statistics & numerical data | Interferon-alpha - therapeutic use | Liver Cirrhosis, Biliary - drug therapy | Medroxyprogesterone Acetate - therapeutic use | Pleural Effusion - drug therapy | Treatment Outcome | Computer Simulation - statistics & numerical data | Penicillamine - therapeutic use | Kidney Neoplasms - mortality | Breast Neoplasms - drug therapy | Tamoxifen - therapeutic use | Survival Analysis | Breast Neoplasms - mortality | Drug Therapy, Combination - statistics & numerical data | Kidney Neoplasms - drug therapy | Analysis | Confidence intervals | Simulation | Medical statistics | Clinical outcomes | Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 10/2017, Volume 108, Issue 10, pp. 2022 - 2029
Journal Article